Journal article

Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-cap randomized clinical trial

Abstract:: Importance The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown.
Objective To determine the effect of multiple interventions for critically ill adults with COVID-19 on longer-term outcomes.
Design, Setting, and Participants Prespecified secondary analysis of an ongoing adaptive platform trial (REMAP-CAP) testing interventions within multiple therapeutic domains in which 4... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Higgins, A., Berry, L., Lorenzi, E., Murthy, S., McQuilten, Z., Mouncey, P., Al-Beidh, F., Annane, D., Arabi, Y., Beane, A., van Bentum-Puijk, W., Bhimani, Z., Bonten, M., Bradbury, C., Brunkhorst, F., Burrell, A., Buzgau, A., Buxton, M., Charles, W., … Saunders, C. (2022). Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-cap randomized clinical trial. JAMA, 329(1), 39–51.

MLA Style

Higgins, AM, et al. “Long-Term (180-Day) Outcomes in Critically Ill Patients with COVID-19 in the REMAP-Cap Randomized Clinical Trial.” JAMA, vol. 329, no. 1, 2022, pp. 39–51.

Chicago Style

Higgins, AM, LR Berry, E. Lorenzi, et al. 2022. “Long-Term (180-Day) Outcomes in Critically Ill Patients with COVID-19 in the REMAP-Cap Randomized Clinical Trial.” JAMA 329 (1): 39–51.
Print

Access Document

Publisher copy:: 10.1001/jama.2022.23257

Authors

+ Higgins, AM More by this author

Role:: Author

+ Berry, LR More by this author

Role:: Author

+ Lorenzi, E More by this author

Role:: Author

+ Murthy, S More by this author

Role:: Author
ORCID:: 0000-0002-9476-839X

+ McQuilten, Z More by this author

Role:: Author

More authors...

Contributors

+ Writing Committee for the REMAP-CAP Investigators

Role:: Contributor

+ European Commission More from this funder

Grant:: 602525
Grant:: 101003589

+ National Institute for Health Research (NIHR) More from this funder

Grant:: Covid-19 - REMAP-CAP

Publisher:: American Medical Association
Journal:: JAMA More from this journal
Volume:: 329
Issue:: 1
Pages:: 39-51
Place of publication:: United States
Publication date:: 2022-12-16
Acceptance date:: 2022-11-30
DOI:: 10.1001/jama.2022.23257
EISSN:: 1538-3598
ISSN:: 0098-7484
Pmid:: 36525245

Language:: English
Keywords:: FFR
Pubs id:: 1316931
Local pid:: pubs:1316931
Deposit date:: 2023-08-16
ARK identifier:: ark:/29072/ora_557df768a15f4323b7816934609f7a6e

Terms of use

Copyright holder:: American Medical Association
Copyright date:: 2023
Rights statement:: © 2023, American Medical Association. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP